|
Q
|
Toxo1
|
Toxoplasma gondii resistance QTL 1
|
|
IDA
|
| |
|
|
RGD |
PMID:16407112 |
RGD:1578521 |
NCBI chr10:52,200,030...59,378,278
|
|
Q
|
Vie1
|
Viral induced encephalitis QTL 1
|
|
IDA
|
| |
26.4
|
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
Q
|
Vie2
|
Viral induced encephalitis QTL 2
|
|
IDA
|
| |
4.1
|
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 3:145,956,084...169,034,231
|
|
Q
|
Vie3
|
Viral induced encephalitis QTL 3
|
|
IDA
|
| |
2.6
|
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 6:96,833,997...140,994,061
|
|
Q
|
Vie4
|
Viral induced encephalitis QTL 4
|
|
IDA
|
| |
7.3
|
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:62,933,508...82,490,359
|
|
Q
|
Vie5
|
Viral induced encephalitis QTL 5
|
|
IDA
|
| |
25.3
|
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
|
Q
|
Bvd1
|
Brain ventricular dilatation QTL 1
|
|
IDA
|
| 0.001 |
3.73
|
|
RGD |
PMID:15473982 |
RGD:1302890 |
NCBI chr 9:75,712,843...111,552,878
|
|
Q
|
Bvd2
|
Brain ventricular dilatation QTL 2
|
|
IDA
|
| 0.001 |
6.36
|
|
RGD |
PMID:15473982 |
RGD:1302890 |
NCBI chr10:93,223,816...107,057,807
|
|
Q
|
Bvd3
|
Brain ventricular dilatation QTL 3
|
|
IDA
|
| 0.001 |
3.64
|
|
RGD |
PMID:15473982 |
RGD:1302890 |
NCBI chr11:69,446,070...82,846,715
|
|
Q
|
Bvd4
|
Brain ventricular dilatation QTL 4
|
|
IDA
|
| 0.001 |
5.31
|
|
RGD |
PMID:15473982 |
RGD:1302890 |
NCBI chr17:53,498,828...82,479,847
|
|
Q
|
Bvd5
|
Brain ventricular dilatation QTL 5
|
|
IDA
|
| 0.001 |
3.51
|
|
RGD |
PMID:15473982 |
RGD:1302890 |
NCBI chr17:31,990,784...81,292,925
|
|
Q
|
Bvd6
|
Brain ventricular dilatation QTL 6
|
|
IDA
|
| 1.0E-4 |
3.1
|
|
RGD |
PMID:11178739 |
RGD:68693 |
NCBI chr11:66,113,321...82,169,223
|
|
|
Q
|
Bp49
|
Blood pressure QTL 49
|
|
IDA
|
| |
16.6
|
|
RGD |
PMID:9241273 |
RGD:61056 |
NCBI chr 5:60,293,434...98,603,051
|
|
Q
|
Strs1
|
Sensitivity to stroke QTL 1
|
|
IDA
|
| |
7.4
|
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 1:121,767,634...166,767,634
|
|
Q
|
Strs2
|
Sensitivity to stroke QTL 2
|
|
IDA
|
| |
4.7
|
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 5:135,929,696...166,875,058
|
|
Q
|
Strs3
|
Sensitivity to stroke QTL 3
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 4:40,433,388...85,433,388
|
|
Q
|
Strs4
|
Sensitivity to stroke QTL 4
|
|
IDA
|
| |
8.7
|
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr 1:78,430,536...123,430,536
|
|
Q
|
Strs5
|
Sensitivity to stroke QTL 5
|
|
IDA
|
| |
9.4
|
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr18:49,999,958...65,845,095
|
|
Q
|
Strs6
|
Sensitivity to stroke QTL 6
|
|
IDA
|
| |
3.9
|
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr 5:134,972,980...138,113,556
|
|
Q
|
Strs7
|
Sensitivity to stroke QTL 7
|
|
IDA
|
| |
3.8
|
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr15:40,289,901...49,308,583
|
|
|
Q
|
Edpm1
|
Estrogen-dependent pituitary mass QTL 1
|
|
IDA
|
| 0.05 |
4.0
|
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 2:35,134,841...88,029,593
|
|
Q
|
Edpm10
|
Estrogen-dependent pituitary mass QTL 10
|
|
IDA
|
| |
2.83
|
|
RGD |
PMID:9337394 |
RGD:61074 |
|
|
Q
|
Edpm11
|
Estrogen-dependent pituitary mass QTL 11
|
|
IDA
|
| |
2.5
|
|
RGD |
PMID:11003699 |
RGD:629550 |
NCBI chr 9:1...43,718,459
|
|
Q
|
Edpm12
|
Estrogen-dependent pituitary mass QTL 12
|
|
IDA
|
| |
3.2
|
|
RGD |
PMID:11003699 |
RGD:629550 |
NCBI chr X:2,927,898...47,927,898
|
|
Q
|
Edpm2
|
Estrogen-dependent pituitary mass QTL 2
|
|
IDA
|
| 0.86 |
4.42
|
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 2:76,539,322...202,447,032
|
|
Q
|
Edpm3
|
Estrogen-dependent pituitary mass QTL 3
|
|
IDA
|
| 0.038 |
7.05
|
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 3:53,184,692...89,878,207
|
|
Q
|
Edpm5
|
Estrogen-dependent pituitary mass QTL 5
|
|
IDA
|
| 0.92 |
4.5
|
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 5:68,984,307...104,251,008
|
|
Q
|
Edpm9
|
Estrogen-dependent pituitary mass QTL 9
|
|
IDA
|
| 0.05 |
3.43
|
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 9:63,869,687...108,869,687
|
|
Q
|
Ept1
|
Estrogen-induced pituitary tumorigenesis QTL 1
|
|
IDA
|
| |
4.4
|
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 6:9,843,312...20,338,915
|
|
Q
|
Ept10
|
Estrogen-induced pituitary tumorigenesis QTL 10
|
|
IDA
|
| |
3.8
|
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:192,825,253...243,914,732
|
|
Q
|
Ept13
|
Estrogen-induced pituitary tumorigenesis QTL 13
|
|
IDA
|
| |
3.4
|
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:77,494,165...122,494,165
|
|
Q
|
Ept15
|
Estrogen-induced pituitary tumorigenesis QTL 15
|
|
IDA
|
| |
4.4
|
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:9,843,312...20,338,915
|
|
Q
|
Ept16
|
Estrogen-induced pituitary tumorigenesis QTL 16
|
|
IDA
|
| |
8.3
|
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 3:47,233,430...110,362,260
|
|
Q
|
Ept17
|
Estrogen-induced pituitary tumorigenesis QTL 17
|
|
IDA
|
| |
6.7
|
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 3:6,537,645...10,778,823
|
|
Q
|
Ept18
|
Estrogen-induced pituitary tumorigenesis QTL 18
|
|
IDA
|
| |
3.9
|
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr10:73,453,136...96,120,911
|
|
Q
|
Ept2
|
Estrogen-induced pituitary tumorigenesis QTL 2
|
|
IDA
|
| |
8.3
|
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:47,233,430...110,362,260
|
|
Q
|
Ept5
|
Estrogen-induced pituitary tumorigenesis QTL 5
|
|
IDA
|
| |
3.8
|
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 4:83,428,419...177,635,233
|
|
Q
|
Ept6
|
Estrogen-induced pituitary tumorigenesis QTL 6
|
|
IDA
|
| |
6.7
|
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:6,537,645...10,778,823
|
|
Q
|
Ept7
|
Estrogen-induced pituitary tumorigenesis QTL 7
|
|
IDA
|
| |
3.7
|
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q
|
Ept9
|
Estrogen-induced pituitary tumorigenesis QTL 9
|
|
IDA
|
| |
3.9
|
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr10:73,453,136...96,120,911
|
|